Plain-English translation of NCT06555042 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Crohn Disease research guide →This trial tests a new imaging approach using two types of PET-MRI scans to detect and measure inflammation in the small bowel of people with suspected Crohn's disease. The scans work together to show where inflammation is happening and how much blood flow is reaching inflamed areas. Researchers hope this combination will help doctors diagnose and understand Crohn's disease more accurately.
Currently, detecting small bowel inflammation in Crohn's disease can be challenging and requires multiple tests. This study aims to see whether combining two advanced imaging techniques can provide a clearer, more complete picture of bowel inflammation in one visit, potentially making diagnosis faster and more accurate.
You likely qualify if…
You likely don't qualify if…
You will have screening tests including blood work and urine tests, then return for an imaging visit where you'll lie still while two types of PET-MRI scans are performed on your small bowel—this takes a few hours and requires fasting beforehand. You'll also have blood and stool samples collected, and tissue biopsies taken during a standard colonoscopy as part of your clinical care. The whole process involves one or two outpatient visits at Turku University Hospital.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Finland